The Jefferson Institute for Bioprocessing is up and running after just two years. How did they do it? And what courses are on offer?

Maeve Magner explains how digital solutions can improve the supply chains of emerging economies.

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

Before you start building a new ATMP facility, there is one essential element that you need to get right: site selection.

A new vaccine could help give people at risk of HIV more options.

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

"Let's adopt a lifecycle management approach to method development to ensure continued excellence."